title: Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs.
abstract: BACKGROUND
  A large number of natural products have shown in vitro antiplasmodial activities. Early identification and prioritization of these natural products with potential for novel mechanism of action, desirable pharmacokinetics and likelihood for development into drugs is advantageous. Chemo-informatic profiling of these natural products were conducted and compared to currently registered anti-malarial drugs (CRAD).
  
  
  METHODS
  Natural products with in vitro antiplasmodial activities (NAA) were compiled from various sources. These natural products were sub-divided into four groups based on inhibitory concentration (IC50). Key molecular descriptors and physicochemical properties were computed for these compounds and analysis of variance used to assess statistical significance amongst the sets of compounds. Molecular similarity analysis, estimation of drug-likeness, in silico pharmacokinetic profiling, and exploration of structure-activity landscape were also carried out on these sets of compounds.
  
  
  RESULTS
  A total of 1040 natural products were selected and a total of 13 molecular descriptors were analysed. Significant differences were observed among the sub-groups of NAA and CRAD for at least 11 of the molecular descriptors, including number of hydrogen bond donors and acceptors, molecular weight, polar and hydrophobic surface areas, chiral centres, oxygen and nitrogen atoms, and shape index. The remaining molecular descriptors, including clogP, number of rotatable bonds and number of aromatic rings, did not show any significant difference when comparing the two compound sets. Molecular similarity and chemical space analysis identified natural products that were structurally diverse from CRAD. Prediction of the pharmacokinetic properties and drug-likeness of these natural products identified over 50% with desirable drug-like properties. Nearly 70% of all natural products were identified as potentially promiscuous compounds. Structure-activity landscape analysis highlighted compound pairs that form 'activity cliffs'. In all, prioritization strategies for the NAA were proposed.
  
  
  CONCLUSIONS
  Chemo-informatic profiling of NAA and CRAD have produced a wealth of information that may guide decisions and facilitate anti-malarial drug development from natural products. Articulation of the information provided within an interactive data-mining environment led to a prioritized list of NAA.
authors.affiliation: South African Medial Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, Cape Town, South Africa. segieyeh@sanbi.ac.za.|School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa. segieyeh@sanbi.ac.za.
authors.forename: Samuel Ayodele
authors.initials: SA
authors.lastname: Egieyeh
authors.affiliation: School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa. jsyce@uwc.ac.za.
authors.forename: James
authors.initials: J
authors.lastname: Syce
authors.affiliation: School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa. sfmalan@uwc.ac.za.
authors.forename: Sarel F
authors.initials: SF
authors.lastname: Malan
authors.affiliation: South African Medial Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, Cape Town, South Africa. alan@sanbi.ac.za.
authors.forename: Alan
authors.initials: A
authors.lastname: Christoffels
mesh_terms: D000962:Antimalarials / Q000737:chemistry*; D001688:Biological Products / Q000737:chemistry*; D008970:Molecular Weight
chemical_list: D000962:Antimalarials; D001688:Biological Products
references.citation: Nat Rev Drug Discov. 2008 Oct;7(10):818-26
references.pmid: 18787530
references.citation: J Med Chem. 2010 Apr 8;53(7):2719-40
references.pmid: 20131845
references.citation: J Comput Aided Mol Des. 2011 Jul;25(7):663-7
references.pmid: 21614595
references.citation: Nat Chem. 2012 Feb;4(2):90-8
references.pmid: 22270643
references.citation: J Chem Inf Model. 2006 Jul-Aug;46(4):1535
references.pmid: 16859285
references.citation: Nat Rev Drug Discov. 2011 Oct;10(10):749-65
references.pmid: 21959288
references.citation: Bioorg Med Chem Lett. 2008 Sep 1;18(17):4872-5
references.pmid: 18691886
references.citation: ChemMedChem. 2007 Jun;2(6):861-73
references.pmid: 17477341
references.citation: Br J Pharmacol. 2011 Mar;162(6):1239-49
references.pmid: 21091654
references.citation: J Chem Inf Model. 2006 May-Jun;46(3):1060-8
references.pmid: 16711725
references.citation: Bioorg Med Chem Lett. 2005 Feb 15;15(4):1087-90
references.pmid: 15686918
references.citation: J Med Chem. 2012 Nov 26;55(22):9763-72
references.pmid: 23061697
references.citation: Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72
references.pmid: 16381955
references.citation: Drug Discov Today. 2004 May 15;9(10):430-1
references.pmid: 15109945
references.citation: Acc Chem Res. 2010 Aug 17;43(8):1103-14
references.pmid: 20481515
references.citation: J Med Chem. 1995 May 26;38(11):1911-21
references.pmid: 7783123
references.citation: J Med Chem. 2009 Nov 12;52(21):6752-6
references.pmid: 19827778
references.citation: J Med Chem. 2009 Apr 9;52(7):1953-62
references.pmid: 19265440
references.citation: Drug Discov Today Technol. 2004 Dec;1(4):337-41
references.pmid: 24981612
references.citation: J Med Chem. 2012 Feb 9;55(3):1252-60
references.pmid: 22229549
references.citation: Nature. 2004 Apr 1;428(6982):473
references.pmid: 15057811
references.citation: Mol Divers. 2006 Feb;10(1):39-79
references.pmid: 16404528
references.citation: Nat Rev Drug Discov. 2009 Mar;8(3):203-12
references.pmid: 19247303
references.citation: Curr Drug Metab. 2002 Dec;3(6):647-57
references.pmid: 12369891
references.citation: Med Res Rev. 2003 May;23(3):275-301
references.pmid: 12647311
references.citation: Drug Metab Rev. 1995;27(1-2):147-77
references.pmid: 7641574
references.citation: Curr Opin Chem Biol. 2003 Jun;7(3):402-8
references.pmid: 12826129
references.citation: J Med Chem. 2012 Aug 23;55(16):7003-9
references.pmid: 22712563
references.citation: Comb Chem High Throughput Screen. 2004 Nov;7(7):631-43
references.pmid: 15578925
references.citation: Drug Discov Today. 2009 Mar;14(5-6):261-70
references.pmid: 19231313
references.citation: Phytochemistry. 2001 Feb;56(3):237-43
references.pmid: 11243450
references.citation: ChemMedChem. 2007 Jun;2(6):874-80
references.pmid: 17492703
references.citation: Nat Rev Drug Discov. 2007 Nov;6(11):881-90
references.pmid: 17971784
references.citation: Pharm Res. 1987 Jun;4(3):258-60
references.pmid: 3509293
references.citation: ACS Chem Neurosci. 2010 Jun 16;1(6):420-34
references.pmid: 22778836
references.citation: Bioorg Med Chem Lett. 2010 Sep 1;20(17):5308-12
references.pmid: 20655216
references.citation: Curr Drug Metab. 2008 Nov;9(9):952-64
references.pmid: 18991592
references.citation: Oxid Med Cell Longev. 2010 Jul-Aug;3(4):238-53
references.pmid: 20972370
references.citation: J Chem Inf Model. 2011 Aug 22;51(8):1848-56
references.pmid: 21761918
references.citation: J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):218-27
references.pmid: 12546556
references.citation: J Med Chem. 2008 Feb 28;51(4):817-34
references.pmid: 18232648
references.citation: Expert Opin Drug Discov. 2014 Sep;9(9):995-1003
references.pmid: 24955724
references.citation: J Inorg Biochem. 2008 Aug;102(8):1660-7
references.pmid: 18508124
references.citation: J Chem Inf Model. 2015 Feb 23;55(2):460-73
references.pmid: 25558886
references.citation: J Med Chem. 2002 Jun 6;45(12):2615-23
references.pmid: 12036371
references.citation: J Biol. 2008;7(10):38
references.pmid: 19090980
references.citation: Drug Discov Today. 2009 Nov;14(21-22):1011-20
references.pmid: 19729075
references.citation: J Biol Chem. 2009 Sep 25;284(39):26797-802
references.pmid: 19648119
references.citation: Molecules. 2009;14(8):3037-72
references.pmid: 19701144
references.citation: Planta Med. 2014 Sep;80(14):1161-70
references.pmid: 24310213
references.citation: J Med Chem. 2012 Apr 12;55(7):2932-42
references.pmid: 22236250
references.citation: Drug Discov Today. 2012 Jul;17(13-14):718-26
references.pmid: 22515962
references.citation: J Med Chem. 2012 Jul 12;55(13):5989-6001
references.pmid: 22537178
references.citation: Expert Opin Drug Discov. 2012 Oct;7(10):863-75
references.pmid: 22992175
references.citation: Acta Pharm Sin B. 2014 Feb;4(1):3-17
references.pmid: 26579359
references.citation: J Biochem Biophys Methods. 2002 Dec 31;54(1-3):1-9
references.pmid: 12543488
references.citation: Chem Biol. 2014 Sep 18;21(9):1115-42
references.pmid: 25237858
references.citation: J Nat Prod. 2007 May;70(5):789-94
references.pmid: 17439280
references.citation: Curr Top Med Chem. 2006;6(14):1473-82
references.pmid: 16918463
references.citation: J Med Chem. 2000 Oct 19;43(21):3867-77
references.pmid: 11052792
references.citation: Adv Exp Med Biol. 2001;500:521-4
references.pmid: 11764991
references.citation: Curr Opin Chem Biol. 2010 Jun;14(3):308-14
references.pmid: 20202892
references.citation: Bioimpacts. 2013;3(1):21-7
references.pmid: 23678466
references.citation: Trans R Soc Trop Med Hyg. 2008 Jan;102(1):11-9
references.pmid: 18035385
references.citation: Drug Discov Today. 2013 Jul;18(13-14):659-66
references.pmid: 23458995
references.citation: Health Aff (Millwood). 2007 May-Jun;26(3):684-95
references.pmid: 17485745
references.citation: Nat Rev Drug Discov. 2011 Mar;10(3):197-208
references.pmid: 21358739
references.citation: Curr Opin Chem Biol. 2006 Aug;10(4):357-61
references.pmid: 16814592
references.citation: Bioorg Med Chem Lett. 2009 Oct 15;19(20):5857-60
references.pmid: 19748778
references.citation: Bioorg Med Chem. 2009 May 1;17(9):3229-56
references.pmid: 19299148
references.citation: Curr Opin Chem Biol. 2008 Jun;12(3):306-17
references.pmid: 18423384
references.citation: Bioorg Med Chem Lett. 2009 Oct 1;19(19):5560-4
references.pmid: 19720530
references.citation: Drug Discov Today. 2009 Jul;14(13-14):698-705
references.pmid: 19410012
references.citation: ISRN Pharm. 2013 Dec 26;2013:848043
references.pmid: 24459591
references.citation: J Cheminform. 2011 Oct 07;3:33
references.pmid: 21982300
references.citation: Health Aff (Millwood). 2006 Mar-Apr;25(2):420-8
references.pmid: 16522582
references.citation: J Med Chem. 2008 Oct 9;51(19):6075-84
references.pmid: 18798611
references.citation: Wiley Interdiscip Rev Comput Mol Sci. 2012 Nov;2(6):null
references.pmid: 24163705
references.citation: Drug Discov Today. 2000 Jul;5(7):294-300
references.pmid: 10856912
references.citation: F1000Res. 2013 Sep 30;2:199
references.pmid: 24555097
references.citation: Toxicol Sci. 2009 Jul;110(1):4-30
references.pmid: 19414517
references.citation: Chirality. 1989;1(1):2-6
references.pmid: 2642032
references.citation: J Mol Model. 2002 Dec;8(12):337-49
references.pmid: 12541001
references.citation: Drug Discov Today. 2005 Jul 15;10(14):987-92
references.pmid: 16023057
references.citation: Prim Care Companion J Clin Psychiatry. 2003 Apr;5(2):70-73
references.pmid: 15156233
references.citation: J Mol Biol. 1988 Jun 20;201(4):751-4
references.pmid: 3172202
references.citation: Gen Pharmacol. 1996 Jun;27(4):713-22
references.pmid: 8853310
references.citation: Malar J. 2011;10 Suppl 1:S3
references.pmid: 21411014
references.citation: J Med Chem. 2010 Jul 22;53(14):5061-84
references.pmid: 20345171
references.citation: Mol Biosyst. 2006 Sep;2(9):430-46
references.pmid: 17153140
references.citation: Nat Rev Drug Discov. 2012 May;11(5):355-65
references.pmid: 22543468
references.citation: J Chem Inf Comput Sci. 2001 May-Jun;41(3):856-64
references.pmid: 11410068
references.citation: Curr Top Med Chem. 2011;11(7):760-70
references.pmid: 21291399